Fast Facts

Chairman, President and CEO – Brian Markison

Stock Exchange Listing – NYSE (KG)

Headquarters – Bristol, Tennessee

• Commercial Operations – Bridgewater, NJ
• Manufacturing
  • Bristol, TN
  • Rochester, MI
  • St. Louis, MO
  • St. Petersburg, FL
  • Middleton, WI
• Research & Development
  • Cary, NC
• Meridian Medical Technologies
  • Columbia, MD

Web Site Address – www.kingpharm.com

Employees – 2,000+

Sales Force – 690

Named

• Top 9 Best Managed Drug Companies
  by Fortune – January 2006
• The reality of virtual R&D

Year Founded – January 1994

For Press Release Information, click here.

Key Products

• Avinza® CII
• Skelaxin®
• Thrombin-JMI®
• Altace®
• Levoxyl®
• Cytomel^®
• Sonata® CIV
• Meridian Auto injector Products/EpiPen®

R&D Pipeline

Late Stage

• Remoxy™

• Acurox™ Tablets

• CorVue^®

• Thrombi-Gel

• Vanquix^®

Early to Mid Stage

• T-62

• Sonedenoson

• Oradur™ Platform

• Aversion^® Technology Platform

Core Competencies

• Commercialization and marketing:
  690 member sales force with strengths in primary care, neuroscience and hospital.
• Scientific Operations:
  Approximately 100 employees specializing in core R&D, pharmacovigilance, clinical operation, regulatory affairs, medical affairs and project management.
• Business development
• Manufacturing and quality control:
  produce a broad array of dosage forms including tablets, capsules, liquids, suspensions, solutions, suppositories, creams, ointments, injectables, auto-injector products, and other drug products.

This page was last updated on 3/17/2008.